• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?

作者信息

Fong Kimberlee S, Fatica Cynthia, Hall Geraldine, Procop Gary, Schindler Susan, Gordon Steven M, Fraser Thomas G

出版信息

Infect Control Hosp Epidemiol. 2011 Sep;32(9):932-3. doi: 10.1086/661789.

DOI:10.1086/661789
PMID:21828981
Abstract
摘要

相似文献

1
Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?艰难梭菌聚合酶链反应检测对发病率及公共报告可能性的影响：竞争环境公平吗？
Infect Control Hosp Epidemiol. 2011 Sep;32(9):932-3. doi: 10.1086/661789.
2
Public reporting of Clostridium difficile and improvements in diagnostic tests.艰难梭菌的公开报告及诊断测试的改进
Infect Control Hosp Epidemiol. 2011 Dec;32(12):1231-2; author reply 1233. doi: 10.1086/663014.
3
Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.产毒艰难梭菌聚合酶链反应检测对临床微生物学实验室和住院患者流行病学的影响。
Diagn Microbiol Infect Dis. 2013 Aug;76(4):534-8. doi: 10.1016/j.diagmicrobio.2013.04.020. Epub 2013 Jun 2.
4
Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.实时聚合酶链反应检测无症状艰难梭菌定植及艰难梭菌相关疾病发病率上升
Infect Control Hosp Epidemiol. 2014 Jun;35(6):667-73. doi: 10.1086/676433. Epub 2014 Apr 22.
5
Reported Clostridium difficile rates: accurate and targeting the problem?
J Hosp Infect. 2007 Oct;67(2):197-8. doi: 10.1016/j.jhin.2007.08.003. Epub 2007 Sep 19.
6
Repeated stool toxin testing for diagnosing difficile colitis is still valid.
South Med J. 2009 Oct;102(10):993-4. doi: 10.1097/SMJ.0b013e3181b4b0a6.
7
Clostridium difficile infection: a comprehensive review.艰难梭菌感染：全面综述。
Crit Rev Microbiol. 2011 Aug;37(3):178-87. doi: 10.3109/1040841X.2011.556598. Epub 2011 May 24.
8
Necessary but not sufficient: a comparison of surveillance definitions of Clostridium difficile-associated diarrhea.必要但不充分：艰难梭菌相关性腹泻监测定义的比较
Infect Control Hosp Epidemiol. 2009 Apr;30(4):377-9. doi: 10.1086/596505.
9
Surveillance for Clostridium difficile-associated diarrhea in long-term care facilities: what you get is not what you see.长期护理机构中艰难梭菌相关性腹泻的监测：实际情况并非所见那样。
Infect Control Hosp Epidemiol. 2008 Aug;29(8):760-3. doi: 10.1086/589812.
10
Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006.2006年，法国艰难梭菌毒素型III（PCR核糖体分型027）相关疾病的出现
Euro Surveill. 2006 Sep 14;11(9):E060914.1. doi: 10.2807/esw.11.37.03044-en.

引用本文的文献

1
Impact of Nucleic Acid Amplification Test on Clinical Outcomes in Patients with Infection.核酸扩增检测对感染患者临床结局的影响
Antibiotics (Basel). 2023 Feb 21;12(3):428. doi: 10.3390/antibiotics12030428.
2
Impact of the Introduction of a Two-Step Laboratory Diagnostic Algorithm in the Incidence and Earlier Diagnosis of Infection.两步实验室诊断算法的引入对感染发病率及早期诊断的影响
Microorganisms. 2022 May 23;10(5):1075. doi: 10.3390/microorganisms10051075.
3
Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
两步法检测艰难梭菌在区分儿童感染与定植方面并不充分。
J Pediatr Gastroenterol Nutr. 2021 Mar 1;72(3):378-383. doi: 10.1097/MPG.0000000000002944.
4
Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II.诊断方法对贝佐妥昔单抗预防艰难梭菌反复感染3期临床试验结果的影响：MODIFY I/II事后分析
Open Forum Infect Dis. 2019 Aug 1;6(8). doi: 10.1093/ofid/ofz293.
5
Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.医疗机构对儿童艰难梭菌（梭状芽孢杆菌）检测的诊断实践：一项新兴传染病网络调查。
Infect Control Hosp Epidemiol. 2019 Mar;40(3):276-280. doi: 10.1017/ice.2018.347. Epub 2019 Feb 15.
6
Impact of the introduction of a nucleic acid amplification test for diagnosis on stool rejection policies.引入核酸扩增检测用于诊断对粪便拒收政策的影响。
Gut Pathog. 2018 May 30;10:19. doi: 10.1186/s13099-018-0245-x. eCollection 2018.
7
Clostridium difficile stool shedding in infants hospitalized in two neonatal intensive care units is lower than previous point prevalence estimates using molecular diagnostic methods.在两个新生儿重症监护病房住院的婴儿中，艰难梭菌粪便排出率低于先前使用分子诊断方法得出的现患率估计值。
BMC Pediatr. 2018 Apr 13;18(1):137. doi: 10.1186/s12887-018-1113-z.
8
Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing.与检测差异相关的艰难梭菌感染率的人为差异。
Emerg Infect Dis. 2018 Mar;24(3):584-587. doi: 10.3201/eid2403.170961.
9
Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics.优化艰难梭菌分子诊断的诊断预测价值的策略
J Clin Microbiol. 2017 May;55(5):1244-1248. doi: 10.1128/JCM.00147-17. Epub 2017 Mar 8.
10
Recent Advances in the Diagnosis and Treatment of Clostridium Difficile Infection.艰难梭菌感染的诊断与治疗新进展
F1000Res. 2016 Jan 29;5. doi: 10.12688/f1000research.7109.1. eCollection 2016.